IL307277A - Therapeutic material for gait disorders - Google Patents
Therapeutic material for gait disordersInfo
- Publication number
- IL307277A IL307277A IL307277A IL30727723A IL307277A IL 307277 A IL307277 A IL 307277A IL 307277 A IL307277 A IL 307277A IL 30727723 A IL30727723 A IL 30727723A IL 307277 A IL307277 A IL 307277A
- Authority
- IL
- Israel
- Prior art keywords
- therapeutic agent
- gait disturbance
- gait
- disturbance
- therapeutic
- Prior art date
Links
- 206010017577 Gait disturbance Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021060178 | 2021-03-31 | ||
| PCT/JP2022/016648 WO2022211052A1 (ja) | 2021-03-31 | 2022-03-31 | 歩行障害治療剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL307277A true IL307277A (en) | 2023-11-01 |
Family
ID=83456587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL307277A IL307277A (en) | 2021-03-31 | 2022-03-31 | Therapeutic material for gait disorders |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240197724A1 (https=) |
| EP (1) | EP4316489A4 (https=) |
| JP (1) | JPWO2022211052A1 (https=) |
| KR (1) | KR20230165247A (https=) |
| CN (1) | CN117157075A (https=) |
| AU (1) | AU2022248664A1 (https=) |
| BR (1) | BR112023019899A2 (https=) |
| CA (1) | CA3215414A1 (https=) |
| IL (1) | IL307277A (https=) |
| TW (1) | TW202304444A (https=) |
| WO (1) | WO2022211052A1 (https=) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI316055B (https=) | 2001-04-26 | 2009-10-21 | Nippon Shinyaku Co Ltd | |
| HRP20151443T1 (hr) * | 2008-06-23 | 2016-01-29 | Nippon Shinyaku Co., Ltd. | Terapijsko sredstvo protiv stenoze kralježniäśnog kanala |
| ES2762943T3 (es) * | 2015-09-03 | 2020-05-26 | Teva Pharmaceuticals Int Gmbh | Formas de Selexipag en estado sólido |
-
2022
- 2022-03-31 CA CA3215414A patent/CA3215414A1/en active Pending
- 2022-03-31 KR KR1020237034284A patent/KR20230165247A/ko active Pending
- 2022-03-31 IL IL307277A patent/IL307277A/en unknown
- 2022-03-31 TW TW111112395A patent/TW202304444A/zh unknown
- 2022-03-31 BR BR112023019899A patent/BR112023019899A2/pt unknown
- 2022-03-31 AU AU2022248664A patent/AU2022248664A1/en active Pending
- 2022-03-31 US US18/284,941 patent/US20240197724A1/en active Pending
- 2022-03-31 JP JP2023511724A patent/JPWO2022211052A1/ja active Pending
- 2022-03-31 CN CN202280023976.3A patent/CN117157075A/zh active Pending
- 2022-03-31 WO PCT/JP2022/016648 patent/WO2022211052A1/ja not_active Ceased
- 2022-03-31 EP EP22781262.5A patent/EP4316489A4/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4316489A1 (en) | 2024-02-07 |
| WO2022211052A1 (ja) | 2022-10-06 |
| CN117157075A (zh) | 2023-12-01 |
| KR20230165247A (ko) | 2023-12-05 |
| TW202304444A (zh) | 2023-02-01 |
| AU2022248664A1 (en) | 2023-10-12 |
| EP4316489A4 (en) | 2025-03-26 |
| US20240197724A1 (en) | 2024-06-20 |
| BR112023019899A2 (pt) | 2023-11-07 |
| JPWO2022211052A1 (https=) | 2022-10-06 |
| CA3215414A1 (en) | 2022-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB202005852D0 (en) | Therapeutic compounds | |
| GB202005863D0 (en) | Therapeutic compounds | |
| GB202006960D0 (en) | Therapeutic | |
| GB202001980D0 (en) | Therapeutic mentods | |
| GB202103640D0 (en) | Therapeutic compounds | |
| IL307277A (en) | Therapeutic material for gait disorders | |
| GB202201139D0 (en) | Therapeutic agent | |
| GB202109583D0 (en) | Therapeutic agents | |
| GB202103642D0 (en) | Therapeutic compounds | |
| GB202010606D0 (en) | Therapeutic agents | |
| GB202105643D0 (en) | Therapeutic agent | |
| GB202105657D0 (en) | Therapeutic agent | |
| GB202115770D0 (en) | Therapeutic agents | |
| GB202115366D0 (en) | therapeutic agents | |
| GB202114792D0 (en) | Therapeutic agents | |
| GB202114507D0 (en) | Therapeutic agents | |
| GB202114429D0 (en) | Therapeutic agents | |
| GB202112860D0 (en) | Therapeutic agents | |
| GB202111639D0 (en) | Therapeutic agents | |
| GB202110567D0 (en) | Therapeutic agents | |
| GB202110120D0 (en) | Therapeutic agents | |
| GB202109520D0 (en) | Therapeutic agents | |
| GB202108945D0 (en) | Therapeutic agents | |
| GB202019702D0 (en) | Therapeutic agents | |
| GB202017641D0 (en) | Therapeutic agents |